Request Appointment
1275 York AvenueNew York, NY 10065
Overview of Dr. Shahrokni
Dr. Armin Shahrokni is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Hackensack Meridian Health Jersey Shore University Medical Center. He received his medical degree from Shahid Beheshti University of Medical Sciences and has been in practice 13 years. He is one of 508 doctors at Memorial Sloan Kettering Cancer Center and one of 43 doctors at Hackensack Meridian Health Jersey Shore University Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Griffin HospitalResidency, Internal Medicine/Public Health and General Preventive Medicine, 2006 - 2010
Shahid Beheshti University of Medical SciencesClass of 2004
Certifications & Licensure
CA State Medical License 2010 - Present
FL State Medical License 2025 - Present
NJ State Medical License 2020 - 2027
NY State Medical License 2013 - 2026
American Board of Internal Medicine Geriatric Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy. Start of enrollment: 2016 May 01
- Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer Start of enrollment: 2019 Mar 19
- A Study of a Telemedicine Program for Older Adults With Cancer Start of enrollment: 2021 Jun 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Randomized Clinical Trial of Geriatric Comanagement Versus Geriatric Assessment-Guided Supportive Care for Older Patients With Head and Neck Cancer.Kaveh Zakeri, Amir H Safavi, Daphna Gelblum, Linda Chen, Armin Shahrokni
Journal of the National Comprehensive Cancer Network. 2025-08-13 - Correction to: Association between geriatric co‑management and receipt of rehabilitation services in the inpatient postoperative period among older adults with cancer.Kiran K Bhurtyal, Amy L Tin, Andrew J Vickers, Armin Shahrokni
Supportive Care in Cancer. 2025-03-13 - Association between geriatric co-management and receipt of rehabilitation services in the inpatient postoperative period among older adults with cancer.Kiran K Bhurtyal, Amy L Tin, Andrew J Vickers, Armin Shahrokni
Supportive Care in Cancer. 2025-02-01
Journal Articles
- Association of Geriatric Comanagement and 90-Day Postoperative Mortality Among Patients Aged 75 Years and Older with CancerArmin Shahrokni, Beatriz Korc-Grodzicki, JAMA Network Open
- The Age of Talking About Age Alone Is OverArmin Shahrokni, MD, Annals of Surgical Oncology
Lectures
- Fitness scale-4 item (FS4) to predict six-month postoperative mortality of cancer patients aged 75.2019 ASCO Annual Meeting - 6/1/2019
- Reduced 90-day postoperative mortality through geriatric comanagement after cancer surgery.2019 ASCO Annual Meeting - 6/1/2019
- A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- Association of Geriatric Comanagement and 90-Day Postoperative Mortality Among Patients Aged 75 Years and Older with CancerAugust 2020
Press Mentions
COVID-19 : This Is How Older Adults with Chronic Diseases Can Assess Whether to Get VaccinatedJanuary 28th, 2021
Are the Coronavirus Vaccines Safe for Someone with Cancer, Dementia or MS?January 27th, 2021- It Takes A Team to Improve Surgery Outcomes in EldersAugust 21st, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
